- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05715788
Prone Positioning vs. Prone Positioning and NO Inhalation in COVID-19 ARDS.
February 4, 2023 updated by: Shanghai Zhongshan Hospital
Prone Positioning Versus Prone Positioning and NO Inhalation in COVID-19 Associated Acute Respiratory Distress Syndrome.
The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS.
Patients with COVID-19-associated ARDS were ventilated in prone position with or without NO inhalation, the arterial blood gas (ABG) tests were performed at 16 hours after prone positioning.
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ming Zhong, PhD
- Phone Number: (021) 6564 2662
- Email: zhong.ming@zs-hospital.sh.cn
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Recruiting
- Zhongshan Hospital, Fudan University
-
Contact:
- Ming Zhong, PhD
- Phone Number: 021-65642662
- Email: zhong.ming@zs-hospital.sh.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with COVID-19 associated ARDS
Description
Inclusion Criteria:
- Adult patients with COVID-19 associated ARDS
Exclusion Criteria:
- patients who have contraindication for prone positioning, including pregnant, post-abdomen surgery within a week; hypercapnic respiratory failure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
patients ventilated in prone position
Patients ventilated in prone position
|
vatilation in prone position
Other Names:
|
Patients ventilated in prone position with NO inhalation
|
vatilation in prone position
Other Names:
Nitric oxide inhalation at 20 ppm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
P/F ratio
Time Frame: 16 hours
|
P/F ratios in each group
|
16 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Ming Zhong, PhD, Fudan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 21, 2022
Primary Completion (ANTICIPATED)
December 1, 2023
Study Completion (ANTICIPATED)
December 1, 2023
Study Registration Dates
First Submitted
February 4, 2023
First Submitted That Met QC Criteria
February 4, 2023
First Posted (ACTUAL)
February 8, 2023
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2023
Last Update Submitted That Met QC Criteria
February 4, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Respiratory Tract Diseases
- Respiration Disorders
- Lung Diseases
- Disease
- Infant, Newborn, Diseases
- Infant, Premature, Diseases
- Syndrome
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Vasodilator Agents
- Autonomic Agents
- Peripheral Nervous System Agents
- Protective Agents
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Antioxidants
- Free Radical Scavengers
- Endothelium-Dependent Relaxing Factors
- Gasotransmitters
- Nitric Oxide
Other Study ID Numbers
- ppv-vs-ppvno
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome
-
Tanta UniversityRecruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Respiratory Distress Syndrome, PediatricEgypt
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Dr Anna Lavizzari; Dr Francesca Gaia CiuffiniCompletedNewborn Respiratory Distress SyndromeItaly
-
University Hospital, Clermont-FerrandWithdrawn
-
Assiut UniversityRecruitingNeonatal Respiratory DistressEgypt
-
Groupe Hospitalier Paris Saint JosephCompletedEarly Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year (DROPE)Neonatal Respiratory Distress SyndromeFrance
-
Karolinska University HospitalCompletedRespiratory Distress Syndrome, Adult | Respiratory Distress Syndrome, ChildSweden
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Respiratory Distress Syndrome ARDS
-
Michael A. MatthayThe University of Texas Health Science Center, Houston; United States Department... and other collaboratorsCompletedRespiratory Distress Syndrome, AdultUnited States
-
Faron Pharmaceuticals LtdSeventh Framework ProgrammeTerminatedRespiratory Distress Syndrome, AdultSpain, United Kingdom, France, Italy, Finland, Czechia, Belgium, Germany
-
Postgraduate Institute of Medical Education and...TerminatedAcute Respiratory Distress Syndrome (ARDS)India
Clinical Trials on prone positioning
-
Ayub Medical College, AbbottabadAyub Teaching HospitalCompletedCOVID-19 Pneumonia | COVID-19 Acute Respiratory Distress Syndrome | Prone PositioningPakistan
-
Johns Hopkins UniversityWest Penn Allegheny Health SystemRecruiting
-
Poudre Valley Health SystemRecruiting
-
University of Lausanne HospitalsCompletedARDS | Sars-CoV-2 InfectionSwitzerland
-
Centre Hospitalier Bretagne AtlantiqueCompletedARDS | Prone PositioningFrance
-
Dhritiman ChakrabartiCompleted
-
Policlinico HospitalCompleted
-
National Institute of Nursing Research (NINR)National Institutes of Health (NIH)Completed
-
Istanbul University - Cerrahpasa (IUC)RecruitingRespiratory Failure | Acute Respiratory Distress Syndrome | Ventilation Perfusion MismatchTurkey
-
University of Milano BicoccaCompleted